European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum biointact parathyroid hormone based on weekly samplings from 91 healthy participants
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The European Biological Variation Study (EuBIVAS) was created by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group on Biological Variation to establish high-quality biological variation (BV) estimates for clinically important measurands. In this study, the aim was to deliver reliable BV estimates for the biointact parathyroid hormone (PTH 1-84). METHODS: Serum samples were obtained from a population of 91 healthy individuals (38 men, 43 pre-menopausal women, and 10 post-menopausal women; 21-69 years) from 5 European countries, with all samples stored at -80 °C prior to analysis. PTH 1-84 analysis was performed at the San Raffaele Hospital (Milan, Italy) on the Roche Cobas e801. All samples from each individual were analysed in duplicate within a single run. CV-ANOVA was applied, after analysis of variance homogeneity and outliers, to obtain BV estimates for PTH 1-84 with 95% CIs. RESULTS: (95% CI)] were similar (men: 26.8% (21.4-35.1%), pre-menopausal women: 27.8% (22.7-36.1%)], allowing for delivery of updated analytical performance specifications and reference change values. CONCLUSIONS: Updated BV estimates for serum PTH 1-84 based on the large-scale EuBIVAS may be beneficial for the diagnosis and management of parathyroid glands and bone turnover pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This includes a high number of smokers and the highest mean BMI in the Turkish cohort [18], which may explain the higher TSH results that were found in this group.”
From European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“EuBIVAS BV estimates produce not only stricter APS, but consequently also smaller RCVs, indicating that smaller changes between serial measurements are of significance than previously indicated when using RCVs derived from historical BV data [24, 25, 29].”
From The European Biological Variation Study (EuBIVAS): a summary report (2022) · cites this paper as [29]
Experimental — accuracy not yet measuredIn the citing paper
“We have previously reported lifestyle differences between the country-defined EuBIVAS study cohorts [18].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An analysis of variance test for normality (complete samples)
SHAPIRO, S. S., & WILK, M. B. (1965) · Biometrika · doi:10.1093/biomet/52.3-4.591 · Cited by 23,480 · cited 1×
“The CVG estimates were obtained using ANOVA on the natural log-transformed data after outliers between subjects were identified by the Dixon q-test (33) and the verification of the normality assumption by the ShapiroWilk test (34).”
MethodAn Analysis of Variance Test for Normality (Complete Samples)
Shapiro, S. S., & Wilk, M. B. (1965) · Biometrika · doi:10.2307/2333709 · Cited by 23,469
(2017) · Kidney International Supplements · doi:10.1016/j.kisu.2017.04.001 · Cited by 1,956
Dixon, W. J. (1953) · Biometrics · doi:10.2307/3001634 · Cited by 868
Sandberg, S., Fraser, C. G., Horvath, A. R., Jansen, R., Jones, G., Oosterhuis, W., Petersen, P. H., Schimmel, H., Sikaris, K., & Panteghini, M. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0067 · Cited by 563 · cited 1×
“The availability of reliable biological variation (BV) data for PTH is essential for defining analytical performance specifications (APS), which are utilized to assess the suitability and the quality of analytical methods (5,6).”
MethodSelf-citationTHE DISTRIBUTION OF THE LARGEST OF A SET OF ESTIMATED VARIANCES AS A FRACTION OF THEIR TOTAL
COCHRAN, W. G. (1941) · Annals of Eugenics · doi:10.1111/j.1469-1809.1941.tb02271.x · Cited by 438 · cited 1×
“Assessment for outliers between replicates (for CVA) and for variance homogeneity (for CVI) was performed by Bartlett’s test (31) and by the Cochran test (32), respectively.”
MethodFraser, C. G. (2012) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2011.733 · Cited by 286 · cited 1×
“Additionally, BV data are used to establish reference change value (RCV), which may be applied to assess the significance of change when performing serial measurements in a subject, as a tool for patient monitoring (7).”
MethodAarsand, A. K., Røraas, T., Fernandez-Calle, P., Ricos, C., Díaz-Garzón, J., Jonker, N., Perich, C., González-Lao, E., Carobene, A., Minchinela, J., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.281808 · Cited by 233 · cited 2×
“EuBIVAS is a large-scale, fully BIVAC compliant BV study (all 14 quality items were scored as A), including 91 participants from 5 different European countries, and from which a number of studies have been already published (11,23-29).”
MethodSelf-citationBiological Variability of Plasma Intact and C-Terminal FGF23 Measurements
Smith, E. R., Cai, M. M., McMahon, L. P., & Holt, S. G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1811 · Cited by 214 · cited 3×
“Considering the studies performed in healthy populations: 2 declared to assess the biointact PTH (PTH 1-84) BV using third-generation assays (15,19); 4 the intact PTH BV using second-generation assays (12,15,19,21), whereas 4 did not specify the assay used for PTH evaluation and thus it is not clear whether the obtain…”
BackgroundMethodSerum parathyroid hormone level is associated with body mass index. The 5th Tromso study
Kamycheva, E., Sundsfjord, J., & Jorde, R. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510167 · Cited by 212 · cited 1×
“In addition, the positive correlation between PTH 1-84 and BMI in men (see Figure 3) is a feature already described in literature (39).”
BackgroundAnalytical performance characteristics should be judged against objective quality specifications
Fraser, C. G., & Petersen, P. H. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.3.321 · Cited by 194 · cited 1×
“The availability of reliable biological variation (BV) data for PTH is essential for defining analytical performance specifications (APS), which are utilized to assess the suitability and the quality of analytical methods (5,6).”
MethodReference Change Values for Brain Natriuretic Peptides Revisited
Fokkema, M. R., Herrmann, Z., Muskiet, F. A., & Moecks, J. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.069369 · Cited by 176 · cited 1×
“The APS for the analytical imprecision (CVAPS) and analytical bias (BAPS), and the RCV were calculated as described in (27,36).”
MethodPhysiology of Parathyroid Hormone
Goltzman, D. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.07.003 · Cited by 176
A checklist for critical appraisal of studies of biological variation
Bartlett, W. A., Braga, F., Carobene, A., Coşkun, A., Prusa, R., Fernandez-Calle, P., Røraas, T., Jonker, N., Sandberg, S., & Variati, O. B. O. T. B. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1127 · Cited by 151 · cited 1×
“(22), designed the European Biological Variation Study (EuBIVAS).”
BackgroundSelf-citationVariability of biomarkers in patients with chronic heart failure and healthy controls
Meijers, W. C., van der Velde, A. R., Muller Kobold, A. C., Dijck-Brouwer, J., Wu, A. H., Jaffe, A., & de Boer, R. A. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.669 · Cited by 146 · cited 3×
“Considering the studies performed in healthy populations: 2 declared to assess the biointact PTH (PTH 1-84) BV using third-generation assays (15,19); 4 the intact PTH BV using second-generation assays (12,15,19,21), whereas 4 did not specify the assay used for PTH evaluation and thus it is not clear whether the obtain…”
BackgroundMethodChanges in Biochemical Markers of Osteoblastic Activity during the Menstrual Cycle*
NIELSEN, H. K., BRIXEN, K., BOUILLON, R., & MOSEKILDE, L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1431 · Cited by 135 · cited 1×
“The differences in PTH 1-84 mean values between the women <50 years and both men and women >50 years (Table 2, Figure 2) underline that PTH 1-84 concentrations are affected by sex and premenopausal status, as previously described (37,38).”
Røraas, T., Støve, B., Petersen, P. H., & Sandberg, S. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.252296 · Cited by 128 · cited 1×
“Data analysis The CV-ANOVA, an ANOVA method based on the CVtransformation of data (30), was used to analyze PTH 1-84 data and to produce estimates of analytical variation (CVA) and CVI.”
MethodSelf-citationCarobene, A., Strollo, M., Jonker, N., Barla, G., Bartlett, W. A., Sandberg, S., Sylte, M. S., Røraas, T., Sølvik, U. Ø., Fernandez-Calle, P., et al. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0035 · Cited by 110 · cited 2×
“The EuBIVAS project Detailed information about involved laboratories, exclusion/inclusion criteria for subjects’ enrolment, and protocols for sample collection, handling, and storage, has been previously published in detail (23).”
BackgroundSelf-citationAarsand, A. K., Díaz-Garzón, J., Fernandez-Calle, P., Guerra, E., Locatelli, M., Bartlett, W. A., Sandberg, S., Røraas, T., Ceriotti, F., Sølvik, U. Ø., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.288415 · Cited by 105 · cited 2×
“EuBIVAS is a large-scale, fully BIVAC compliant BV study (all 14 quality items were scored as A), including 91 participants from 5 different European countries, and from which a number of studies have been already published (11,23-29).”
MethodSelf-citationBiological variation database: structure and criteria used for generation and update
Perich, C., Minchinela, J., Ricós, C., Fernández-Calle, P., Alvarez, V., Doménech, M. V., Simón, M., Biosca, C., Boned, B., García-Lario, J. V., et al. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0739 · Cited by 98
Zittermann, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.95 · Cited by 96 · cited 1×
“The differences in PTH 1-84 mean values between the women <50 years and both men and women >50 years (Table 2, Figure 2) underline that PTH 1-84 concentrations are affected by sex and premenopausal status, as previously described (37,38).”
Gardham, C., Stevens, P. E., Delaney, M. P., LeRoux, M., Coleman, A., & Lamb, E. J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09471209 · Cited by 87 · cited 8×
“Considering the studies performed in healthy populations: 2 declared to assess the biointact PTH (PTH 1-84) BV using third-generation assays (15,19); 4 the intact PTH BV using second-generation assays (12,15,19,21), whereas 4 did not specify the assay used for PTH evaluation and thus it is not clear whether the obtain…”
BackgroundMethodResultInfluentialHanon, É. A., Sturgeon, C. M., & Lamb, E. J. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0315 · Cited by 82
Carobene, A., Marino, I., Coşkun, A., Serteser, M., Unsal, I., Guerra, E., Bartlett, W. A., Sandberg, S., Aarsand, A. K., Sylte, M. S., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.275115 · Cited by 77 · cited 1×
“EuBIVAS is a large-scale, fully BIVAC compliant BV study (all 14 quality items were scored as A), including 91 participants from 5 different European countries, and from which a number of studies have been already published (11,23-29).”
Self-citationReference change values: the way forward in monitoring
Fraser, C. G. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009006 · Cited by 72 · cited 1×
“In this case, the RCV formula should be adapted for obtaining a Z value and thus for the 1-tailed change value calculation, which can be considered as the critical increase between two consecutive results of an analyte, using the following formula: Z = change/[2 (CVA 2 + CVI (2))] (41).”
MethodSahai, H., & Ojeda, M. M. (2004) · Birkhäuser Boston eBooks · doi:10.1007/978-0-8176-8168-5 · Cited by 69 · cited 1×
“The 95% CI for BV estimates (35) and mean concentrations were calculated.”
MethodSturgeon, C. M., Sprague, S. M., Almond, A., Cavalier, E., Fraser, W. D., Algeciras‐Schimnich, A., Singh, R. J., Souberbielle, J., & Vesper, H. W. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.10.016 · Cited by 68 · cited 6×
“PTH is a key biomarker for diagnosing of parathyroid glands’ pathologies, calcium-phosphate metabolism disorders and for monitoring chronic kidney disease mineral and bone disorder (CKD-MBD).”
BackgroundInfluentialHow the reference values for serum parathyroid hormone concentration are (or should be) established?
Souberbielle, J., Brazier, F., Piketty, M., Cormier, C., Minisola, S., & Cavalier, E. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0553-2 · Cited by 66 · cited 4×
“An important clinical question (e.g., in CKD-MBD subjects) is when an increase in two consecutive PTH 1-84 evaluations is significant.”
BackgroundInfluentialBiological Variation Estimates Obtained from 91 Healthy Study Participants for 9 Enzymes in Serum
Carobene, A., Røraas, T., Sølvik, U. Ø., Sylte, M. S., Sandberg, S., Guerra, E., Marino, I., Jonker, N., Barla, G., Bartlett, W. A., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.269811 · Cited by 63 · cited 1×
“EuBIVAS is a large-scale, fully BIVAC compliant BV study (all 14 quality items were scored as A), including 91 participants from 5 different European countries, and from which a number of studies have been already published (11,23-29).”
Self-citationAnkrah-Tetteh, T., Wijeratne, S., & Swaminathan, R. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2007.007103 · Cited by 59 · cited 4×
“Considering the studies performed in healthy populations: 2 declared to assess the biointact PTH (PTH 1-84) BV using third-generation assays (15,19); 4 the intact PTH BV using second-generation assays (12,15,19,21), whereas 4 did not specify the assay used for PTH evaluation and thus it is not clear whether the obtain…”
BackgroundMethodInfluentialCarobene, A., Aarsand, A. K., Guerra, E., Bartlett, W. A., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Jonker, N., Locatelli, M., Sandberg, S., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.304618 · Cited by 53 · cited 1×
“EuBIVAS is a large-scale, fully BIVAC compliant BV study (all 14 quality items were scored as A), including 91 participants from 5 different European countries, and from which a number of studies have been already published (11,23-29).”
Self-citationDupuy, A., Cristol, J., Vincent, B., Bargnoux, A. S., Mendes, M., Philibert, P., Klouche, K., & Badiou, S. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0292 · Cited by 51
Carobene, A., Guerra, E., Locatelli, M., Cucchiara, V., Briganti, A., Aarsand, A. K., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Røraas, T., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.043 · Cited by 47 · cited 1×
“EuBIVAS is a large-scale, fully BIVAC compliant BV study (all 14 quality items were scored as A), including 91 participants from 5 different European countries, and from which a number of studies have been already published (11,23-29).”
Self-citationCavalier, E., Delanaye, P., & Moranne, O. P. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.12.013 · Cited by 37 · cited 2×
“For PTH, ten studies have been identified by systematic literature review (12-21), all of which have received a BIVAC grade C.”
BackgroundMethodA Bayesian Approach to Biological Variation Analysis
Røraas, T., Sandberg, S., Aarsand, A. K., & Støve, B. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.300145 · Cited by 35 · cited 1×
“A recently published Bayesian model for estimating BV is robust to “noisy data” and is an approach for delivering BV estimates without the need for data trimming (40).”
MethodSelf-citationAnalytical quality goals for parathyroid hormone based on biological variation
Viljoen, A., Singh, D. K., Twomey, P. J., & Farrington, K. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.275 · Cited by 26 · cited 3×
“Considering the studies performed in healthy populations: 2 declared to assess the biointact PTH (PTH 1-84) BV using third-generation assays (15,19); 4 the intact PTH BV using second-generation assays (12,15,19,21), whereas 4 did not specify the assay used for PTH evaluation and thus it is not clear whether the obtain…”
BackgroundMethodCarobene, A., Guerra, E., Locatelli, M., Ceriotti, F., Sandberg, S., Fernandez-Calle, P., Coşkun, A., & Aarsand, A. K. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.292169 · Cited by 22 · cited 1×
“EuBIVAS is a large-scale, fully BIVAC compliant BV study (all 14 quality items were scored as A), including 91 participants from 5 different European countries, and from which a number of studies have been already published (11,23-29).”
Self-citationWhat Is Hypercalcemia? The Importance of Fasting Samples
Siyam, F. F., & Klachko, D. M. (2013) · Cardiorenal Medicine · doi:10.1159/000355526 · Cited by 19 · cited 1×
“The EuBIVAS CVI estimates were lower than those delivered by previously published papers on biointact PTH, possibly related to different statistical approaches and to the strict control of the fasting status, thus minimizing possible effects of the ingestion of calcium-containing nutrients (42).”
MethodBIOLOGICAL VARIABILITY OF BIOCHEMICAL MARKERS OF BONE TURNOVER IN HEALTHY WOMEN
Takahashi, M., Kawana, K., & Nagano, A. (2002) · Endocrine Research · doi:10.1081/erc-120015063 · Cited by 18 · cited 2×
“Considering the studies performed in healthy populations: 2 declared to assess the biointact PTH (PTH 1-84) BV using third-generation assays (15,19); 4 the intact PTH BV using second-generation assays (12,15,19,21), whereas 4 did not specify the assay used for PTH evaluation and thus it is not clear whether the obtain…”
BackgroundMethodShort-term Variability of Vitamin D–Related Biomarkers
Lutsey, P. L., Parrinello, C. M., Misialek, J. R., Hoofnagle, A. N., Henderson, C. M., Laha, T. J., Michos, E. D., Eckfeldt, J. H., & Selvin, E. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.261461 · Cited by 17 · cited 2×
“For PTH, ten studies have been identified by systematic literature review (12-21), all of which have received a BIVAC grade C.”
BackgroundMethodSchleck, M.-L., Souberbielle, J., Delanaye, P., Plebani, M., & Cavalier, E. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0914 · Cited by 17 · cited 5×
“Considering the studies performed in healthy populations: 2 declared to assess the biointact PTH (PTH 1-84) BV using third-generation assays (15,19); 4 the intact PTH BV using second-generation assays (12,15,19,21), whereas 4 did not specify the assay used for PTH evaluation and thus it is not clear whether the obtain…”
BackgroundMethodResultInfluentialDetermining biological variation of serum parathyroid hormone in healthy adults
Ercan, M., Avcı, E., Serdar, M. A., Turhan, T., Oğuz, E. F., Yücel, Ç., & Akbulut, E. D. (2019) · Biochemia Medica · doi:10.11613/bm.2019.030702 · Cited by 8 · cited 7×
“Considering the studies performed in healthy populations: 2 declared to assess the biointact PTH (PTH 1-84) BV using third-generation assays (15,19); 4 the intact PTH BV using second-generation assays (12,15,19,21), whereas 4 did not specify the assay used for PTH evaluation and thus it is not clear whether the obtain…”
BackgroundMethodInfluential
Research works printed but not linked: 1
- Snedecor GW, Cochran WG. Statistical methods. 8th ed. Press ISU, 1991.
Cited by
The European Biological Variation Study (EuBIVAS): a summary report
Carobene, A., Aarsand, A. K., Bartlett, W. A., Coskun, A., Diaz-Garzon, J., Fernandez-Calle, P., Guerra, E., Jonker, N., Locatelli, M., Plebani, M., et al. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0370 · Cited by 84
“Trig, urea, uric acid, α1 acid glycoprotein (AGP), Immunoglobulin A (IgA), soluble transferrin receptor (sTFR), lipoprotein(a) (Lp(a)), biointact parathyroid hormone (PTH 1–84), alpha fetoprotein (AFP), activated partial thromboplastin time (APTT), protein C (prot C) and protein S free (free Prot S), sex related diffe…”
BackgroundResultSelf-citationBiological variation: recent development and future challenges
Sandberg, S., Carobene, A., Bartlett, W. A., Coşkun, A., Fernández–Calle, P., Jonker, N., Díaz–Garzón, J., & Aarsand, A. K. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1255 · Cited by 65
Self-citationBottani, M., Aarsand, A. K., Banfi, G., Locatelli, M., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Sandberg, S., Ceriotti, F., & Carobene, A. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1885 · Cited by 46
“We have previously reported lifestyle differences between the country-defined EuBIVAS study cohorts [18].”
InfluentialSelf-citationCarobene, A., Campagner, A., Uccheddu, C., Banfi, G., Vidali, M., & Cabitza, F. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0599 · Cited by 22
Self-citationDetermination of parathyroid hormone: from radioimmunoassay to LCMS/MS
Cavalier, E. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0942 · Cited by 18
Metadata
- Authors
- on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation, Bottani, M., Banfi, G., Guerra, E., Locatelli, M., Aarsand, A. K., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Sandberg, S., Ceriotti, F., González-Lao, E., Simon, M., & Carobene, A.
- Affiliations
- IRCCS Ospedale Galeazzi - Sant'Ambrogio (IT)
- Vita-Salute San Raffaele University (IT)
- IRCCS Ospedale San Raffaele (IT)
- Haukeland University Hospital (NO)
- Acıbadem University (TR)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Corresponding author
- Bottani, Michela
- ORCID
- Venue
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Published
- 2020-07
- Volume
- 8
- Issue
- 14
- Pages
- 855-855
- ISSN
- 2305-5839 (ISSN-L)
- 2305-5847
- PMC
- PMC7396758
- OpenAlex
- W3045451334
- Cited by
- 15
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 6
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Annals of Translational Medicine (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Acibadem University Open Access Repository (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- Ministero della Salute
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Physical Sciences › Physics and Astronomy › Instrumentation › Scientific Measurement and Uncertainty Evaluation
- Keywords
- parathyroid hormone, PTH(1-84), biological variation, within-person variability, interindividual variability, reference change value, healthy volunteers, menopausal status, analytical performance specifications, bone turnover
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.